Drug Search Results
More Filters [+]

Rimexolone

Alternative Names: rimexolone, vexol
Latest Update: 2016-06-29
Latest Update Note: Clinical Trial Update

Product Description

Rimexolone is as effective as prednisolone acetate ophthalmic suspension in the treatment of anterior uveitis (Sourced from: https://pubmed.ncbi.nlm.nih.gov/15847313/)

Mechanisms of Action: GR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Bangladesh | Brazil | Canada | Chile | Colombia | Egypt | Germany | Ireland | Italy | Mexico | Morocco | New Zealand | Peru | Portugal | Sweden | Taiwan | Turkey | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rimexolone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title